Posted February 26, 2013
Glenn Walter, Ph.D., University of Florida
One of the major limitations of identifying and evaluating novel DMD therapeutic interventions is the lack of effective techniques to monitor muscle cell response. Dr. Glenn Walter and his research team at the University of Florida will evaluate the ability of contrast agent indocyanine green to detect muscle damage, muscle blood flow, and drug delivery using near infrared (NIR) imaging techniques. The long-term goal of Dr. Walter's research is to establish NIR imaging, a low-cost nonionizing imaging technology, as a tool for monitoring muscle permeability and therapeutic agent delivery along with providing clinically useful information for diagnostic and prognostic purposes in patients with neuromuscular diseases.